Australia markets closed

Sartorius AG (SRT.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
324.50-4.50 (-1.37%)
At close: 09:55PM CET
Full screen
Previous close329.00
Bid324.50 x 12800
Ask328.00 x 8900
Day's range322.00 - 330.00
52-week range262.00 - 565.00
Avg. volume154
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date26 Jan 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Sartorius with continued growth in a challenging environment

    The life science group Sartorius closed the first nine months of 2022 in both divisions with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year.

  • PR Newswire

    Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

    The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications, for example as an animal-free additive to cell culture media and for the stabilization of vaccines and viral thera

  • PR Newswire

    Resolutions of the Annual General Shareholders' Meeting of Sartorius AG

    At today's virtual Annual General Shareholders' Meeting, the shareholders of Sartorius AG granted discharge to the Executive Board and the Supervisory Board and approved the boards' proposals by a large majority. They passed the resolution to pay dividends of 1,26 euros per preference share and 1.25 euros per ordinary share. The total amount disbursed will be 85.9 million euros. In the previous year, dividends were 0.71 euros per preference share and 0.70 euros per ordinary share.